NM_024164.6:c.718G>A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_024164.6(TPSB2):c.718G>A(p.Gly240Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024164.6 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPSB2 | NM_024164.6 | c.718G>A | p.Gly240Ser | missense_variant | Exon 6 of 6 | ENST00000606293.5 | NP_077078.5 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 18
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 18
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.718G>A (p.G240S) alteration is located in exon 6 (coding exon 5) of the TPSB2 gene. This alteration results from a G to A substitution at nucleotide position 718, causing the glycine (G) at amino acid position 240 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at